Seelos Therapeutics, Inc.
SEELQ
$0.0005
$0.000.00%
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 1.71M | -2.66M | -5.45M | 10.50M | -29.50M |
| Total Depreciation and Amortization | 15.00K | 15.00K | 15.00K | 14.00K | 14.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -4.00M | -2.45M | -1.60M | -22.13M | 19.61M |
| Change in Net Operating Assets | 1.30M | 456.00K | 5.13M | 5.87M | 3.97M |
| Cash from Operations | -972.00K | -4.64M | -1.91M | -5.75M | -5.90M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -185.00K | -1.31M | -2.15M | -1.89M | -2.31M |
| Issuance of Common Stock | 927.00K | 3.48M | 4.48M | 4.38M | 0.00 |
| Repurchase of Common Stock | -- | -- | 0.00 | 0.00 | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 742.00K | 2.17M | 2.32M | 2.49M | -2.31M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -230.00K | -2.47M | 412.00K | -3.26M | -8.22M |